CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Tocilizumab

Last Updated: May 27, 2010
Result type: Reports
Project Number: S0201
Product Line: Common Drug Review

Generic Name: Tocilizumab

Brand Name: Actemra

Manufacturer: Hoffmann-La Roche Limited

Indications: Arthritis, Rheumatoid

Submission Type: New

Project Status: Complete

Date Recommendation Issued: November 17, 2010

Recommendation Type: List with clinical criteria and/or conditions